U.S. FDA agrees to extend shelf life of J&J COVID-19 vaccine, says company |
Clinical News
eMediNexus Coverage from: 
U.S. FDA agrees to extend shelf life of J&J COVID-19 vaccine, says company

0 Read Comments                

Johnson & Johnson has stated that the U.S. Food and Drug Administration extended the shelf life of its COVID-19 vaccine from four-and-a-half months to six months.The decision came after the data obtained from ongoing studies indicated that the vaccine is stable at six months while refrigerated at 2 to 8 degrees Celsius or 36-46 degrees Fahrenheit. The agency stated, in a letter to the company, that it had reviewed the data provided by J&J, and on the basis of the information provided, it...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now
advertisment